세계의 원격 환자 모니터링(RPM) 시장 평가 : 제품별, 용도별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Global remote patient monitoring market is projected to witness a CAGR of 13.26% during the forecast period 2024-2031, growing from USD 9.53 billion in 2023 to USD 25.8 billion in 2031. The market expansion is supported by the growing awareness about the various cost benefits associated with remote patient monitoring (RPM) and telehealth and rising investments towards RPM by various key players in the market. Remote patient monitoring systems and devices are often used to help patients who require post-discharge care or are suffering from chronic diseases. Using RPM solutions to monitor the health and vitals of high-risk patients allows organizations to stay updated with data between patient visits and notify them about any potential health issues. RPM devices enhance patient engagement, improve care, and allow patients to have better access to healthcare. Due to the growing awareness about the various advantages associated with the utilization of remote patient monitoring devices and services, several hospitals are adopting such systems, thereby acting as a major growth-inducing factor.

For instance, in 2023, AJ Hospital and Research Centre in Mangaluru adopted an AI-based continuous and contactless remote patient monitoring (RPM) and early warning system (EWS) created by Dozee on fifty beds in their private ward. The early warning system allows the tracking of vital parameters and ensures the provision of alerts to healthcare providers for timely medical intervention in case of patient's clinical deterioration.

Increasing Investments and Strategic Collaborations Support Market Growth

Rising investments by various hospitals and healthcare centers towards remote patient monitoring systems and software to enhance patient convenience and improve patient care is bolstering the remote patient monitoring market growth. In January 2024, a renowned multispecialty hospital in Bangalore, Apollo Hospital Seshadripuram, announced a partnership with an AI-powered health monitoring technology company called LifeSigns. The collaboration is expected to mark a significant advancement in proactive patient management and precision healthcare by empowering the hospital with a wireless remote patient monitoring system. The hospital's commitment to digital transformation will ensure the continuous integration of upgraded LifeSigns solutions in their core operations. They are also going to ensure that the systems are available to all their patients from now onwards. The system uses biosensors for continuously tracking vital signs, including SPO2, blood pressure, and ECG, among others. The secure transmission of real-time data to a platform accessible to healthcare professionals will facilitate continuous monitoring, allowing early identification of any potential complications.

Rising Prevalence of Chronic Diseases and Geriatric Population Boosts Market Expansion

The growing awareness about the various advantages associated with the adoption of remote patient monitoring for the management of chronic diseases is providing lucrative growth opportunities to the market. Various healthcare providers are leveraging remote patient monitoring to provide care for patients suffering from chronic diseases, including cancer, diabetes, cardiovascular diseases, and chronic lung diseases. RPM allows healthcare providers to collect relevant data, track patient health, and make necessary interventions to avoid adverse events. Remote patient management acts as a valuable tool for chronic disease management by tracking the vitals of the patients and alerting them and their caregivers and healthcare providers about necessary information. For instance, in diabetes, RPM tracks the blood sugar levels of the patient, along with physical activity and insulin intake. Remote patient monitoring aims to provide better care to patients by understanding their condition and closely tracking their progress. According to the World Health Organization (WHO), by around 2050, various chronic diseases, including diabetes, cardiovascular diseases, respiratory diseases, and cancer, will account for 86% of the 90 million deaths every year. The remote patient monitoring market demand is increasing due to the growing prevalence of such chronic diseases.

North America Accounts for a Significant Share of the Market

The expansion of the market in the region can be attributed to growing emphasis on the adoption of the Internet of Things (IoT) medical devices, rising investments in telehealth, and the strong presence of various market players. As per a Harvard Health Letter article published in December 2022, approximately 50 million individuals in the United States alone use remote patient monitoring devices. One of the first RPM devices to be adopted was home blood pressure machines. The increasing prevalence of heart diseases and strokes in the region is further bolstering the demand for remote patient monitoring devices. According to Centre for Disease Control and Prevention, over 877,500 Americans die from stroke and heart diseases, among other cardiovascular diseases every year. Heart disease is the leading cause of death in the United States, while stroke takes the fifth position among all deaths in the United States. Remote patient monitoring allows the utilization of electronic devices to record relevant data of a patient for review and evaluation later by their healthcare provider or physician.

For instance, a patient can use RPM devices for regular monitoring of their blood pressure and share the results with their regular physician. The increasing awareness about the various advantages associated with the utilization of RPM devices is supporting the growth of the North America remote patient monitoring market.

Special Monitors Anticipated to Witness Significant Growth in the Coming Years

The increase in utilization and demand of special monitors, such as blood glucose monitors, anesthesia monitors, and multi-parameter monitors, over the forecast period can be attributed to the growing requirement for monitoring clinically important and pre- and post-surgery data for identification of systems and prevention of complications.

For instance, regularly monitoring blood glucose levels is essential for patients with diabetes as they, at times, do not feel any symptoms that are associated with diabetes until the blood glucose levels become too high. The utilization of RPM devices for monitoring blood glucose levels allows practitioners to use the captured data for detecting potential alarming changes in the levels of glucose and take necessary actions immediately. Additionally, the collected data can also provide insights to practitioners that will aid them in recommending necessary alterations in exercise, medications, and diet. Remote patient monitoring also allows the effective mitigation of gestational diabetes. As per the Centre for Disease Control and Prevention, approximately 1-2% of pregnant women in the United States have either Type 1 or Type 2 diabetes and nearly 6-9% of women develop gestational diabetes during pregnancy.

Rising Utilization of RPM for Cardiovascular Diseases

The potential of remote patient monitoring in reducing the burden of managing and monitoring cardiovascular diseases is resulting in a burgeoning volume of research. The research activities aim to evaluate the economic and clinical effectiveness of RPM. According to an article published by American Heart Association, it is projected that by 2035, over 42% of adults in the United States will be hypertensive. The cost projections for hypertension are daunting, with 2035 figures to soar over USD 150 billion. Remote patient monitoring is expected to serve as a vital conduit for reducing the economic burden stemming from expensive hospital stays because of acute hypertension related events. Research has shown that remote patient monitoring can reduce diastolic blood pressure and systolic blood pressure significantly as compared to self-monitoring. Additional studies have shown that the positive impact of remote patient monitoring on systolic blood pressure can increase if the intervention includes multiple behavior change techniques and is long-term.

Future Market Scenario (2024 - 2031F)

The broader use of remote patient monitoring, guided with operational knowledge and high-quality research, is expected to support advancements in hospitals and at home models of care. It has significant potential to benefit from the value provided by healing in the comfort of home.

In February 2024, MD Revolution announced that their partner, Cardiac Solutions, achieved a 50% reduction in the rate of hospital cardiovascular readmission by using chronic care management and RevUp Remote Patient Monitoring as part of their program. The conducted study showed sustained benefits on an annual basis and demonstrated high cost-saving potential and efficacy.

Key Players Landscape and Outlook

Key participants in the remote patient monitoring market include OMRON Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche AG, GE Healthcare, and Abbott Laboratories. In 2023, OMRON Healthcare India announced collaboration with Tricog, a Bengaluru-based firm. This collaboration is expected to be OMRON's foray into remote heart management and monitoring segment.

In May 2023, Abbott received U.S. Food and Drug Administration (FDA) clearance for their Assert-IQ insertable cardiac monitor (ICM). This clearance expands the company's portfolio of connected health devices that can aid doctors in treating their patients remotely.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Remote Patient Monitoring Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Product
  • 4.2.1. Special Monitor
    • 4.2.1.1. Blood Glucose Monitors
    • 4.2.1.2. Anesthesia Monitors
    • 4.2.1.3. Multi-Parameter Monitors
    • 4.2.1.4. Others
  • 4.2.2. Vital Sign Monitor
    • 4.2.2.1. Temperature Monitors
    • 4.2.2.2. Blood Pressure Monitors
    • 4.2.2.3. Respiratory Rate Monitors
    • 4.2.2.4. Others
  • 4.2.3. Software
  • 4.2.4. Services
• 4.3. By Application
  • 4.3.1. Cardiovascular Diseases
  • 4.3.2. Weight Management and Fitness Monitoring
  • 4.3.3. Sleep Disorder
  • 4.3.4. Infections
  • 4.3.5. Cancer
  • 4.3.6. Dehydration
  • 4.3.7. Hypertension
  • 4.3.8. Others
• 4.4. By End-user
  • 4.4.1. Ambulatory Patients
  • 4.4.2. Home Healthcare
  • 4.4.3. Hospital-Based Patients
  • 4.4.4. Others
• 4.5. By Region
  • 4.5.1. North America
  • 4.5.2. South America
  • 4.5.3. Europe
  • 4.5.4. Asia-Pacific
  • 4.5.5. Middle East & Africa
• 4.6. By Company Market Share (%), 2023

5. Global Remote Patient Monitoring Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Product
    • 5.1.2.1. Special Monitors
    • 5.1.2.1.1. Blood Glucose Monitors
    • 5.1.2.1.2. Anesthesia Monitors
    • 5.1.2.1.3. Multi-Parameter Monitors
    • 5.1.2.1.4. Others
    • 5.1.2.2. Vital Sign Monitors
    • 5.1.2.2.1. Temperature Monitors
    • 5.1.2.2.2. Blood Pressure Monitors
    • 5.1.2.2.3. Respiratory Rate Monitors
    • 5.1.2.2.4. Others
    • 5.1.2.3. Software
    • 5.1.2.4. Services
  • 5.1.3. By Application
    • 5.1.3.1. Cardiovascular Diseases
    • 5.1.3.2. Weight Management and Fitness Monitoring
    • 5.1.3.3. Sleep Disorder
    • 5.1.3.4. Infections
    • 5.1.3.5. Cancer
    • 5.1.3.6. Dehydration
    • 5.1.3.7. Hypertension
    • 5.1.3.8. Others
  • 5.1.4. By End-user
    • 5.1.4.1. Ambulatory Patients
    • 5.1.4.2. Home Healthcare
    • 5.1.4.3. Hospital-Based Patients
    • 5.1.4.4. Others
  • 5.1.5. United States*
    • 5.1.5.1. Market Size & Forecast
    • 5.1.5.1.1. By Value
    • 5.1.5.1.2. By Volume
    • 5.1.5.2. By Product
    • 5.1.5.2.1. Special Monitors
    • 5.1.5.2.1.1. Blood Glucose Monitors
    • 5.1.5.2.1.2. Anesthesia Monitors
    • 5.1.5.2.1.3. Multi-Parameter Monitors
    • 5.1.5.2.1.4. Others
    • 5.1.5.2.2. Vital Sign Monitors
    • 5.1.5.2.2.1. Temperature Monitors
    • 5.1.5.2.2.2. Blood Pressure Monitors
    • 5.1.5.2.2.3. Respiratory Rate Monitor
    • 5.1.5.2.2.4. Others
    • 5.1.5.2.3. Software
    • 5.1.5.2.4. Services
    • 5.1.5.3. By Application
    • 5.1.5.3.1. Cardiovascular Diseases
    • 5.1.5.3.2. Weight Management and Fitness Monitoring
    • 5.1.5.3.3. Sleep Disorder
    • 5.1.5.3.4. Infections
    • 5.1.5.3.5. Cancer
    • 5.1.5.3.6. Dehydration
    • 5.1.5.3.7. Hypertension
    • 5.1.5.3.8. Others
    • 5.1.5.4. By End-user
    • 5.1.5.4.1. Ambulatory Patients
    • 5.1.5.4.2. Home Healthcare
    • 5.1.5.4.3. Hospital-Based Patients
    • 5.1.5.4.4. Others
  • 5.1.6. Canada
  • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East & Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Product
• 6.2. By Application
• 6.3. By End-user
• 6.4. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Patent Landscape
• 9.2. Regulatory Approvals
• 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Abbott Laboratories
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. OMRON Corporation
• 13.3. Koninklijke Philips N.V.
• 13.4. F. Hoffmann-La Roche AG
• 13.5. GE Healthcare
• 13.6. Boston Scientific Corporation
• 13.7. Nihon Kohden Corporation
• 13.8. Johnson & Johnson
• 13.9. BIOTRINIK SE & Co.
• 13.10. MD Revolution

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer